However, in the case of BMP-7, a large body of literature in the cancer niche suggests that BMP-7 administration is unlikely to carry significant risk of causing cancer, especially when administered in conditions known to exhibit deficient endogenous BMP-7 levels, such as LN. Here, BMP7 is linked to cancer.